Immunogenicity of BRCA1-deficient ovarian cancers is driven through DNA sensing and is augmented by PARP inhibition

被引：0
|
作者：
Bruand, M. [1 ]
Barras, D. [1 ,2 ]
Mina, M. [3 ]
Lanitis, E. [1 ]
Chong, C. [1 ]
Dorier, J. [2 ]
Walton, J. [4 ]
Bassani-Sternberg, M. [1 ]
Kandalaft, L. [1 ]
McNeish, I. A. [5 ]
Swisher, E. [6 ]
Delorenzi, M. [1 ]
Ren, B. [7 ,8 ]
Ciriello, G. [3 ]
Irving, M. [1 ]
Rusakiewicz, S. [1 ]
Foukas, P. [1 ]
Martinon, F. [9 ]
Dangaj, D. [1 ]
Coukos, G. [1 ]
机构：
[1] Univ Lausanne, Ludwig Inst Canc Res, Dept Oncol, Epalinges, Switzerland
[2] Univ Lausanne, Vital IT, Swiss Inst Bioinformat SIB, Epalinges, Switzerland
[3] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland
[4] Imperial Coll London, Dept Surg & Canc, Ovarian Canc Act Res Ctr, Hammersmith Hosp, London, England
[5] Imperial Coll London, Dept Surg & Canc, London, England
[6] Univ Washington, Seattle Canc Care Alliance, Med, Seattle, WA 98195 USA
[7] Ludwig Inst Canc Res, San Diego Sch Med, Dept Cellular & Mol Med, Inst Genom Med, La Jolla, CA USA
[8] Univ Calif San Diego, La Jolla, CA 92093 USA
[9] Univ Lausanne, Dept Biochem, Lausanne, Switzerland
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1876PD
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Identification of BRCA1-deficient ovarian cancers
    Skytte, Anne-Bine
    Waldstrom, Marianne
    Rasmussen, Anders Aamann
    Cruger, Dorthe
    Woodward, Emma R.
    Kolvraa, Steen
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2011, 90 (06) : 593 - 599
  • [2] PARP inhibition modulates the tumor immune microenvironment in Brca1-deficient ovarian tumor.
    Ding, Liya
    Wang, Qiwei
    Kearns, Michael
    Jiang, Tao
    Konstantinopoulos, Panagiotis
    Matulonis, Ursula
    Zhao, Jean
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 23 - 23
  • [3] PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
    Ding, Liya
    Kim, Hye-Jung
    Wang, Qiwei
    Kearns, Michael
    Jiang, Tao
    Ohlson, Carolynn E.
    Li, Ben B.
    Xie, Shaozhen
    Liu, Joyce F.
    Stover, Elizabeth H.
    Howitt, Brooke E.
    Bronson, Roderick T.
    Lazo, Suzan
    Roberts, Thomas M.
    Freeman, Gordon J.
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    Zhao, Jean J.
    CELL REPORTS, 2018, 25 (11): : 2972 - +
  • [4] CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer
    Higuchi, Tomoe
    Flies, Dallas B.
    Marjon, Nicole A.
    Mantia-Smaldone, Gina
    Ronner, Lukas
    Gimotty, Phyllis A.
    Adams, Sarah F.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (11) : 1257 - 1268
  • [5] Brca1-deficient ovarian cancer cells are sensitized to the DNA-strand-breaking nucleoside analog sapacitabine that synergizes with PARP inhibition
    Liu, Xiaojun
    Jiang, Yingjun
    Nowak, Billie
    Tikhomirova, Dariya
    Plunkett, William
    CANCER RESEARCH, 2015, 75
  • [6] PARP INHIBITION INCREASES IN THE SUPPRESSIVE CAPACITY OF TUMOR-ASSOCIATED TREGS IN A BRCA1-DEFICIENT MODEL OF OVARIAN CANCER
    Falcon, Daniel
    Kinjyo, Ichiko
    Adams, Sarah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1155 - A1155
  • [7] BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers
    Lei, Guang
    Mao, Chao
    Horbath, Amber D.
    Yan, Yuelong
    Cai, Shirong
    Yao, Jun
    Jiang, Yan
    Sun, Mingchuang
    Liu, Xiaoguang
    Cheng, Jun
    Xu, Zhihao
    Lee, Hyemin
    Li, Qidong
    Lu, Zhengze
    Zhuang, Li
    Chen, Mei-Kuang
    Alapati, Anagha
    Yap, Timothy A.
    Hung, Mien-Chie
    You, Mingjian James
    Piwnica-Worms, Helen
    Gan, Boyi
    CANCER DISCOVERY, 2024, 14 (08) : 1476 - 1495
  • [8] Targeting the Akt/mTOR pathway in Brca1-deficient cancers
    Xiang, T.
    Jia, Y.
    Sherris, D.
    Li, S.
    Wang, H.
    Lu, D.
    Yang, Q.
    ONCOGENE, 2011, 30 (21) : 2443 - 2450
  • [9] Targeting the Akt/mTOR pathway in Brca1-deficient cancers
    T Xiang
    Y Jia
    D Sherris
    S Li
    H Wang
    D Lu
    Q Yang
    Oncogene, 2011, 30 : 2443 - 2450
  • [10] Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers
    Sun, Chong-kui
    Zhang, Fan
    Xiang, Tao
    Chen, Qianming
    Pandita, Tej K.
    Huang, Yuping
    Hu, Mickey C. T.
    Yang, Qin
    ONCOTARGET, 2014, 5 (10) : 3375 - 3385
12345